Subject(s)
Antiviral Agents , Respiratory Syncytial Viruses , Humans , Infant , Vaccination , Immunization ScheduleSubject(s)
Advisory Committees , Immunization , Child , Humans , Adult , Adolescent , United States , Infant , Immunization Schedule , Centers for Disease Control and Prevention, U.S. , VaccinationSubject(s)
Family , Vaccination , Adolescent , Adult , Advisory Committees , Child , Humans , Immunization , Immunization Schedule , Infant , United StatesABSTRACT
What are the limits of skin-prick testing? Is prevention possible? And do most children outgrow food allergies? This review provides the evidence to guide your care.
Subject(s)
Anaphylaxis/prevention & control , Evidence-Based Medicine/standards , Family Practice/standards , Food Hypersensitivity/diagnosis , Food Hypersensitivity/prevention & control , Practice Guidelines as Topic , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , United StatesABSTRACT
Use simple practice measures and counsel parents with compelling evidence to help correct the low uptake of this vital vaccine.
Subject(s)
Family Practice/standards , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/administration & dosage , Parents/psychology , Patient Acceptance of Health Care/psychology , Patient Acceptance of Health Care/statistics & numerical data , Practice Guidelines as Topic , Adolescent , Adult , Female , Humans , Immunization/psychology , Immunization/statistics & numerical data , Male , Surveys and Questionnaires , United States , Vaccination/psychology , Vaccination/statistics & numerical dataSubject(s)
Health Communication/methods , Immunization , Physician-Patient Relations , Reminder Systems/classification , Vaccines , Adult , Humans , Immunization/methods , Immunization/psychology , Preventive Health Services/methods , Public Health/methods , Vaccines/classification , Vaccines/therapeutic useABSTRACT
BACKGROUND: The initiation and timely completion of the human papillomavirus (HPV) vaccine in young women is critical. We compared the initiation and completion of the HPV vaccine among women in 2 community-based networks with electronic health records: 1 with a prompt and reminder system (prompted cohort) and 1 without (unprompted cohort). METHODS: Female patients aged 9 to 26 years seen between March 1, 2007, and January 25, 2010, were used as the retrospective cohort. Patient demographics and vaccination dates were extracted from the electronic health records. RESULTS: Patients eligible for the vaccine included 6019 from the prompted cohort and 9096 from the unprompted cohort. Mean age at initiation was 17.3 years in the prompted cohort and 18.1 years in the unprompted cohort. Significantly more (P < .001) patients initiated the vaccine in the prompted cohort (34.9%) compared with the unprompted cohort (21.5%). African Americans aged 9 to 18 years with ≥3 visits during the observation period were significantly more likely to initiate in the prompted cohort (P < .001). The prompted cohort was significantly more likely (P < .001) to complete the vaccine series in a timely manner compared with the unprompted cohort. CONCLUSION: More patients aged 9 to 26 years initiated and achieved timely completion of the HPV vaccine series in clinics using an electronic health record system with prompts compared with clinics without prompts.
Subject(s)
Electronic Health Records , Papillomavirus Vaccines , Patient Compliance/statistics & numerical data , Reminder Systems , Vaccination/statistics & numerical data , Adolescent , Adult , Child , Female , Humans , Retrospective Studies , Young AdultABSTRACT
Quantitative ß-hCG measurements and transvaginal ultrasound findings interpreted in light of a ß-hCG "cutoff" can reliably guide clinical decisions.
Subject(s)
Chorionic Gonadotropin, beta Subunit, Human/blood , Pregnancy, Ectopic/diagnosis , Ultrasonography, Prenatal , Abortifacient Agents, Nonsteroidal/therapeutic use , Adult , Biomarkers/blood , Female , Humans , Methotrexate/therapeutic use , Pregnancy , Pregnancy, Ectopic/blood , Pregnancy, Ectopic/therapy , SalpingostomyABSTRACT
Trigger points are discrete, focal, hyperirritable spots located in a taut band of skeletal muscle. They produce pain locally and in a referred pattern and often accompany chronic musculoskeletal disorders. Acute trauma or repetitive microtrauma may lead to the development of stress on muscle fibers and the formation of trigger points. Patients may have regional, persistent pain resulting in a decreased range of motion in the affected muscles. These include muscles used to maintain body posture, such as those in the neck, shoulders, and pelvic girdle. Trigger points may also manifest as tension headache, tinnitus, temporomandibular joint pain, decreased range of motion in the legs, and low back pain. Palpation of a hypersensitive bundle or nodule of muscle fiber of harder than normal consistency is the physical finding typically associated with a trigger point. Palpation of the trigger point will elicit pain directly over the affected area and/or cause radiation of pain toward a zone of reference and a local twitch response. Various modalities, such as the Spray and Stretch technique, ultrasonography, manipulative therapy and injection, are used to inactivate trigger points. Trigger-point injection has been shown to be one of the most effective treatment modalities to inactivate trigger points and provide prompt relief of symptoms.
